Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0.11Sales per Share
VS
Market
Sector
Industry
History
$ 2.61Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 868K | 1 | 7.84M | $ 0.11 |
| 3/31/2025 | $ 1.85M | 1 | 4.83M | $ 0.38 |
| 12/31/2024 | $ 2.27M | 1 | 2.54M | $ 0.89 |
| 9/30/2024 | $ 2.28M | 1 | 2.65M | $ 0.86 |
| 6/30/2024 | $ 2.4M | 1 | 2.52M | $ 0.96 |
| 3/31/2024 | $ 1.76M | 1 | 1.93M | $ 0.91 |
| 12/31/2023 | $ 1.38M | 1 | 1.82M | $ 0.76 |
| 9/30/2023 | $ 1.24M | 1 | 1.83M | $ 0.68 |
| 6/30/2023 | $ 1.04M | 1 | 1.82M | $ 0.57 |
| 3/31/2023 | $ 581K | 1 | 1.79M | $ 0.32 |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) SPS stands at $ 0.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average SPS has been $ 0.34.
- The median SPS for BIOXCEL THERAPEUTICS INC during this period was $ 0.16
- BIOXCEL THERAPEUTICS INC reached its highest SPS over the past 5 years at $ 0.96.
- The lowest SPS recorded by BIOXCEL THERAPEUTICS INC in the same timeframe $ 0
BIOXCEL THERAPEUTICS INC's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for BIOXCEL THERAPEUTICS INC is calculated as follows: Revenues [ $ 0 ] / (Shares WA [ 1.44M ] * Share Factor [ 1 ])
(=) SPS [ $ 0 ] BTAI - Sales per Share, Last 5 years
$ 0
Minimum
Sep 30, 2020
$ 0.96
Maximum
Jun 30, 2024
$ 0.34
Average
$ 0.16
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.55 with a standard deviation of $ 13.62.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.63K |
|---|---|
| min | $ -18.02 |
| max | $ 54.8 |
| average | $ 11.55 |
| median | $ 5.89 |
| std | $ 13.62 |